Clinical Applications of Gadopiclenol in Cardiac MRI
Credits: 0.5 Category A, ARRT and CRA Format: Text Self-Study
Gadolinium-based contrast agents (GBCAs) continue to advance the diagnostic value of magnetic resonance imaging (MRI), by increasing the sensitivity and specificity for detecting a broad range of cardiac pathologies.
In this CE-accredited program, Mobeen Z Haider, MD, and Robert WW Biederman, MD, FACC, FAHA, FASA, FGSC, FSCMR, share their clinical experience and discuss considerations for selecting and utilizing GBCAs in cardiac MRI. In addition, case study examples demonstrate the clinical impact of gadopiclenol; supported by best practice suggestions for providing effective cardiac MR imaging services.